Salesforce, Inc.

The stock remains in a corrective regime after a strong multi-month run, still well below its 200-day average and far off the 52-week high. That leaves the setup in repair mode, with the recent bounce needing follow-through before the longer-term trend can turn constructive again.

Wall Street stays constructive, with a Buy consensus and a $274 median target versus a $175.35 last close. Recent calls were mixed but still mostly positive: Piper Sandler cut to Neutral, while Cantor, Roth, KeyBanc, Jefferies, and Cowen kept bullish stances or reiterated Buy.

The earnings profile is strong, with 6 of the last 7 quarters beating EPS estimates and the latest quarter topping by 24.0%. Next-year EPS is still modeled higher at 13.115 versus 8.63 TTM, so shareholders should watch whether revenue growth and margin execution keep that upgrade path intact.

No discretionary insider buying or selling stands out. The recent filings are M-exempt share movements by directors, which read as routine administrative activity rather than a conviction signal.

Profitability remains solid, led by a 77.6% gross margin and an 18.7% net margin. Growth is still healthy, with revenue up 13.3% year over year and earnings up 52.2%, while free cash flow reached $15.59 billion for the fiscal year.

CRM still screens as a premium software franchise, supported by scale, 77.6% gross margin, and a broad AI/data platform stack. The stock trades at 20.32x earnings, a valuation that looks reasonable for the group but still depends on sustained growth reacceleration.